IMNP
Immune Pharmaceuticals Inc.
IMNP
IMNP
Delisted
IMNP was delisted on the 25th of July, 2018.
11 hedge funds and large institutions have $1.15M invested in Immune Pharmaceuticals Inc. in 2014 Q3 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
11
Holders Change
+10
Holders Change %
+1,000%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PRCM
1
Pine River Capital Management
Minnetonka,
Minnesota
| $653K | 250,000 | – | – |
|
|
EEG
2
E.E. Geduld
| $134K | 40,000 | +40,000 | New |
|
3
Goldman Sachs
New York
| $105K | 31,143 | +31,143 | New |
|
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $75K | 22,466 | +22,466 | New |
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $67K | 20,000 | +20,000 | New |
|
|
BPCE
6
Bank Pictet & Cie (Europe)
Frankfurt Am Main,
Germany
| $45K | 12,900 | +12,900 | New |
|
|
SIM
7
Spark Investment Management
New York
| $36K | 11,500 | +11,500 | New |
|
8
Morgan Stanley
New York
| $35K | 10,203 | +10,203 | New |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $3K | 881 | +881 | New |
|
|
U
10
UBS
Zurich,
Switzerland
| $0 | 1 | +1 | New |
|
11
Bank of Montreal
Toronto,
Ontario, Canada
| $0 | 1 | +1 | New |
|